YCBD News and Press, cbdMD Inc. From 03/03/22

cbdMD, Inc. ( NYSE American: YCBD, YCBDpA) , (the “Company”) one of the world’s leading and most highly trusted and recognized health & wellness CBD companies, has announced an expansion in product offerings online and in over 840 retail GNC Holdings, LLC (G...

Charlotte, North Carolina--(Newsfile Corp. - February 25, 2022) - cbdMD , Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), (the "Company") one of the world's leading and most highly trusted and recognized health & wellness CBD companies, today announced it has entered into an endorseme...

cbdMD, Inc. ( NYSE American: YCBD, YCBDpA) (the “Company”), one of the world’s leading and most highly trusted and recognized health & wellness CBD companies, today announced that the Natural Products Association (NPA) filed a Citizen’s Petition on cb...

cbdMD Anticipates EU Validation in the Coming Weeks cbdMD, Inc. ( NYSE American: YCBD, YCBDpA) , (the “Company”) announced today that it has received validation of its Novel Food application from the United Kingdom’s Food Standards Agency (“FS...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rise and shine, trader! It’s time to wake up, grab a cup of coffee, and go over the biggest pre-market stock movers for Thursday! Source: oneinchpunch/Shutterstock.com This morning’s stock movement is ...

cbdMD, Inc. (YCBD) Q1 2022 Earnings Conference Call February 10, 2022 4:15 PM ET Company Participants Ronan Kennedy – Chief Financial Officer and Chief Operating Officer Marty Sumichrast – Chairman and Co-Chief Executive Officer Sibyl Swift – Vice President-Scientific &am...

cbdMD press release (NYSE:YCBD): Q1 GAAP EPS of -$0.35 misses by $0.31. Revenue of $9.33M (-24.3% Y/Y) misses by $5.67M. For further details see: cbdMD GAAP EPS of -$0.35 misses by $0.31, revenue of $9.33M misses by $5.67M

Industry Experienced Weakness in CBD Demand in 2021 Resulting In Company YOY Decline in Net Sales for the December 2021 Quarter Company Anticipates Regulatory Action Against the FDA With Expected Filing of Citizens Petition cbdMD, Inc. ( NYSE American: YCBD, ...

The public health organization’s rigorous independent certification includes testing for potentially harmful levels of contaminants and over 280 athletic banned substances, including THC cbdMD, Inc. ( NYSE American: YCBD, YCBDpA) , one of the world’s leadin...

Pricing schemes for CBD products are as variable as the products themselves and impacted by such factors as quality of ingredients, potency, and production. In a pricing analysis that compared over 3000 CBD products across 100 brands, a recent analysis conducted by Leafreport ...